- 询价
- Nebulabio
- 中国
- NBL-296732
- 2026年01月16日
企业认证
相关产品推荐更多 >
![NebuSelect™ Zoxamide, BSA [Antigen]](https://img1.dxycdn.com/p/s14/2025/0919/363/2591836980368398691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Human CEP19 Protein, 1-133aa, His-tag
中文名称：重组人CEP19蛋白
别名：Centrosomal protein of 19 kDa, C3orf34, Cep19, CEP19
货号：NBL-296732
品牌：Nebulabio
规格：100UG；1MG；Bulk
| 产品描述
NebuSelect™ Recombinant Human CEP19 Protein, His-tag (Cat# NBL-296732) is expressed in E. coli with His Tag. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
| 产品属性
Species:Human
Expression System:E. coli
Molecular Weight:18 kDa
Target Name:CEP19
Purity:>90% by SDS-PAGE.
Formulation:See COA
Endotoxin:＜1 EU/ug(LAL Method)
Storage:4°C for short term. -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验8.19 改变思路，Cell子刊发现一个可以逆转癌细胞为正常细胞的蛋白
组织巨噬细胞导致胖子胰岛素抵抗性的机制！脂肪组织巨噬细胞 (adipose tissue macrophages，ATMs) 的促炎激活和积聚与肥胖患者胰岛素抵抗风险的增加有关。近日来自中国香港大学和吉林大学的科学家们在《Science Advances》上发文揭示了硒半胱氨酸插入序列结合蛋白 2 (sequence-binding protein 2，SBP2) 在维持肥胖患者胰岛素敏感性中的作用。研究人员发现特异性敲除肥胖小鼠 ATMs 中的 SBP2 可以通过增加脂肪组织炎症和扩张来促进胰岛
Preparation of Recombinant Protein Spotted Arrays for Proteome‐Wide Identification of Kinase Targets
, H. 2009. Profiling the human protein‐DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139:610‐622. Hudson, J.R., Jr., Dawson, E.P
BioID: A Screen for Protein‐Protein Interactions
to mammalian cells, BioID has potential application in a variety of cell types from diverse species. Curr. Protoc. Protein Sci . 74:19.23.1?19.23.14. © 2013 by John Wiley & Sons, Inc. Keywords: BioID; proximity?dependent labeling; protein
技术资料暂无技术资料 索取技术资料
